Hepatitis C management in primary care has changed

A new direct-acting antiviral (DAA) oral regimen for the treatment...

January 2019

Testing for hepatitis C virus (HCV) in patients at high risk of infection

Hepatitis C infection occurs through exposure to infected blood...

January 2019

Pre-treatment assessment for patients with chronic HCV infection

Patients should be assessed for cirrhosis via clinical examination,...

January 2019

Management and follow-up of patients prescribed glecaprevir + pibrentasvir

Glecaprevir + pibrentasvir is taken once daily for eight weeks....

January 2019

Hepatitis C is now curable:
contributed by Dr Tony Farrell

Dr Tony Farrell is a general practitioner in Mount Maunganui...

January 2019

Hepatitis B: treatments now available for primary care

Tenofovir disoproxil and entecavir are once daily oral antiviral...

August 2018

News item: Discussion on Zostavax

Since publication of our article on Zostavax vaccine in March,...

April 2018

Seasonal influenza vaccination: update for 2018

Two subsidised seasonal influenza vaccines, Influvac Tetra (for...

March 2018

Zostavax vaccine: now fully subsidised

Zostavax is a herpes zoster (shingles) vaccine that will become...

March 2018

Treatment of hepatitis C (HCV) has changed

Three new oral medicine regimens for the treatment of hepatitis...

September 2016

Valaciclovir – a first line antiviral medicine

Valaciclovir is an antiviral medicine which can be used for...

March 2016

Made with by the bpacnz team